29 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

239

Pak Fah Yeow International
HK$2.44-0.8%44.4%HK$760.4mn/aPE7.9xn/a8.8%

2005

SSY Group
HK$3.37-4.3%-28.3%HK$10.0bHK$5.98PE7.3xE6.8%5.3%

1177

Sino Biopharmaceutical
HK$3.21-2.7%1.3%HK$58.4bHK$4.47PE25.6xE13.1%1.8%

2348

Dawnrays Pharmaceutical (Holdings)
HK$1.212.5%18.6%HK$1.8bn/aPE3xn/a6.4%

2161

JBM (Healthcare)
HK$1.84-5.2%100.0%HK$1.5bn/aPE9.1xn/a6.0%

512

Grand Pharmaceutical Group
HK$4.741.3%22.8%HK$16.6bHK$5.80PE6.9xE2.3%5.5%

1093

CSPC Pharmaceutical Group
HK$4.810.2%-30.0%HK$56.0bHK$7.31PE10.2xE3.1%6.6%

2126

JW (Cayman) Therapeutics
HK$1.28-3.8%-42.9%HK$517.9mHK$2.40PS2.8xE-1.8%n/a

690

Uni-Bio Science Group
HK$0.062-1.6%-13.9%HK$370.2mn/aPE3.7xn/an/a

1477

Ocumension Therapeutics
HK$4.47-7.5%-32.6%HK$3.7bHK$9.92PS11xE101.9%n/a

1889

Sanai Health Industry Group
HK$0.410%-73.7%HK$63.5mn/aPE4.6xn/an/a

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.39-3.5%3.7%HK$778.7mn/aPE4.3xn/a38.3%

9939

Kintor Pharmaceutical
HK$0.97-7.6%-37.8%HK$420.0mHK$14.15PB1xE25.8%n/a

2142

HBM Holdings
HK$1.3415.5%-14.6%HK$981.5mn/aPE5.9xn/an/a

6628

Transcenta Holding
HK$0.668.2%-74.7%HK$267.0mHK$8.77PS11.2xE12.7%n/a

6996

Antengene
HK$0.63-1.6%-62.0%HK$428.1mHK$1.69PS7.2xE17.0%n/a

950

Lee's Pharmaceutical Holdings
HK$1.390.7%-7.3%HK$818.5mn/aPE13xn/a2.2%

1521

Frontage Holdings
HK$1.669.9%-20.2%HK$3.4bHK$1.07PE70.8xE67.6%n/a

2137

Brii Biosciences
HK$0.85-5.6%-59.1%HK$621.5mHK$1.00PS15.2xE-7.4%n/a

8225

China Health Group
HK$0.182.3%38.5%HK$179.2mn/aPS6.8xn/an/a

8158

China Regenerative Medicine International
HK$0.35-23.9%-45.3%HK$106.5mn/aPS1.9xn/an/a

2256

Abbisko Cayman
HK$4.34-0.9%24.0%HK$2.7bHK$9.15PS5.1xE-41.7%n/a

2616

CStone Pharmaceuticals
HK$2.30-12.5%6.0%HK$2.9bHK$2.51PS6xE49.9%n/a

1349

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$2.49-5.3%2.9%HK$7.0bn/aPE23xn/a1.7%
Page 1 of 2